Kikot' V A, Iugrinov O G, Galakhin K A, Sorokin B V, Priĭmak V V, Tarasova T A
Klin Khir. 1998(2):20-2.
The combined treatment of 53 patients with colonic cancer, using neoadjuvant intraarterial polychemotherapy (IAPCT), was conducted. The trustworthy lowering of the catheterized artery thrombosis occurrence rate, the tumor recurrence-by 7%, distant metastases-by 13.9%, two-year survival increase-by 15.5% was promoted by verapamil application as a IAPCT modifier.
对53例结肠癌患者采用新辅助动脉内多药化疗(IAPCT)进行联合治疗。作为IAPCT改良剂应用维拉帕米可使导管插入动脉血栓形成发生率、肿瘤复发率降低7%、远处转移率降低13.9%、两年生存率提高15.5%,效果可靠。